Skip to main content

Research Repository

Advanced Search

All Outputs (410)

P033 Evidencing the long-term impact of a musculoskeletal Allied Health Professionals and Nurse Research Internship Programme (2023)
Presentation / Conference
Fry, M., Gavin, J., Finney, A., Ndosi, M., Cramp, F., Lewis, J., …Bowen, C. (2023, April). P033 Evidencing the long-term impact of a musculoskeletal Allied Health Professionals and Nurse Research Internship Programme. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

P083 How are beliefs about osteoporosis medicines elicited and addressed in clinical consultations: a video observational study (2023)
Presentation / Conference
Hawarden, A. W., Bullock, L., León-García, M., Hartasanchez, S. A., Hargraves, I., Horne, R., …Paskins, Z. (2023, April). P083 How are beliefs about osteoporosis medicines elicited and addressed in clinical consultations: a video observational study. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

P203 Comparison of coding of giant cell arteritis in primary and secondary care records: an observational feasibility study (2023)
Presentation / Conference
Padmanabhan, N., Muller, S., Bailey, J., Helliwell, T., Mackie, S. L., Mallen, C. D., & Roddy, E. (2023, April). P203 Comparison of coding of giant cell arteritis in primary and secondary care records: an observational feasibility study. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

Giant cell arteritis (GCA) is considered a medical emergency, and relapses are common, affecting around 50% of patients. Many of the early symptoms of GCA are non-specific and highly prevalent in older people, making the diagnosis challenging. The... Read More about P203 Comparison of coding of giant cell arteritis in primary and secondary care records: an observational feasibility study.

P082 Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise (2023)
Presentation / Conference
Paskins, Z., Moult, A., Corp, N., Bastounis, A., Davis, S., Narayanasamy, M. J., …Sahota, O. (2023, April). P082 Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

P057 Immunosuppression doubles the risk of COVID-19 infection in a large vaccinated cohort of 898 patients with rheumatic diseases: implications for future practice (2023)
Presentation / Conference
Cox, N., & Bateman, J. (2023, April). P057 Immunosuppression doubles the risk of COVID-19 infection in a large vaccinated cohort of 898 patients with rheumatic diseases: implications for future practice. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

P098 Changes in Analgesic Prescribing in Patients with Inflammatory Arthritis in England: An Observational Study in CPRD Aurum (2023)
Presentation / Conference
C Scott, I., Whittle, R., Bailey, J., Twohig, H., L Hider, S., D Mallen, C., …P Jordan, K. (2023, April). P098 Changes in Analgesic Prescribing in Patients with Inflammatory Arthritis in England: An Observational Study in CPRD Aurum. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

Background/Aims Pain is a common symptom experienced by patients with inflammatory arthritis (IA). Emerging data indicate IA pain treatment focuses on prescribing analgesics despite an absence of evidence for long-term efficacy. Delivering optimal,... Read More about P098 Changes in Analgesic Prescribing in Patients with Inflammatory Arthritis in England: An Observational Study in CPRD Aurum.

P102 Barriers and facilitators to lifestyle change in people living with gout: a scoping review of qualitative studies (2023)
Presentation / Conference
Watson, L., Cornwall, N., Jinks, C., Bradbury, K., Goff, L., Little, P., …Roddy, E. (2023, April). P102 Barriers and facilitators to lifestyle change in people living with gout: a scoping review of qualitative studies. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

Background/Aims Lifestyle, especially diet and alcohol, has been implicated in the causation of gout for centuries and the dietary factors which may trigger flares remain of great interest to people living with gout and their families. However, ther... Read More about P102 Barriers and facilitators to lifestyle change in people living with gout: a scoping review of qualitative studies.

P108 Exploring the Treatment Burden of Disease Modifying Anti-Rheumatic Drug Monitoring in People with Rheumatoid Arthritis: A Qualitative Study with Recommendations for Practice (2023)
Presentation / Conference
Ryan, S. J., Bullock, L., Manning, F., Paskins, Z., & Chew-Graham, C. (2023, April). P108 Exploring the Treatment Burden of Disease Modifying Anti-Rheumatic Drug Monitoring in People with Rheumatoid Arthritis: A Qualitative Study with Recommendations for Practice. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

P100 The Impact of Intensive Management on Pain Intensity in Patients with Rheumatoid Arthritis and Psoriatic Arthritis: Secondary Analysis of Three Clinical Trials (2023)
Presentation / Conference
Scott, I. C., Scott, D. L., & Ibrahim, F. (2023, April). P100 The Impact of Intensive Management on Pain Intensity in Patients with Rheumatoid Arthritis and Psoriatic Arthritis: Secondary Analysis of Three Clinical Trials. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

E047 I felt like I’d been given a new lease of life: Exploring the information needs and experiences of people with rheumatoid arthritis receiving bridging glucocorticoids when starting methotrexate (2023)
Presentation / Conference
Logan, S. J., Hider, S., Green, J., & Ryan, S. J. (2023, April). E047 I felt like I’d been given a new lease of life: Exploring the information needs and experiences of people with rheumatoid arthritis receiving bridging glucocorticoids when starting methotrexate. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

P115 Healthcare professionals' perspectives on integrating predictive and emerging preventive approaches in rheumatoid arthritis care: A qualitative investigation (2023)
Presentation / Conference
Simons, G., Wells, I., Kanacherril, J. P., Mallen, C. D., Raza, K., & Falahee, M. (2023, April). P115 Healthcare professionals' perspectives on integrating predictive and emerging preventive approaches in rheumatoid arthritis care: A qualitative investigation. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

P070 Results of a consensus process to determine the elements of a complex digital intervention for distal upper limb musculoskeletal disorders (2023)
Presentation / Conference
Brading, L., Kane, K., McHugh, G., Dziedzic, K., Adams, J., Chopra, S., …Kingsbury, S. (2023, April). P070 Results of a consensus process to determine the elements of a complex digital intervention for distal upper limb musculoskeletal disorders. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

The experiences of remote consulting for people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and fibromyalgia in primary care (2023)
Presentation / Conference
Leach, H., Atherton, H., Eccles, A., & Chew-Graham, C. (2023, March). The experiences of remote consulting for people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and fibromyalgia in primary care. Presented at BJGP Research Conference 2023, London, England, UK

Background Restrictions due to the COVID-19 pandemic resulted in a sudden shift to a predominantly remote consulting model in primary care from March 2020. Little evidence exists examining the experience of remote consulting for people living with ch... Read More about The experiences of remote consulting for people with chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and fibromyalgia in primary care.